Get the Stockscreener App
12.46
4.01%
-0.52
Coeptis Therapeutics Holdings Inc stock is traded at $12.46, with a volume of 41,579.
It is down -4.01% in the last 24 hours and up +17.44% over the past month.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
See More
Previous Close:
$12.98
Open:
$13.19
24h Volume:
41,579
Relative Volume:
0.63
Market Cap:
$71.80M
Revenue:
-
Net Income/Loss:
$-11.62M
P/E Ratio:
-2.225
EPS:
-5.6
Net Cash Flow:
$-6.91M
1W Performance:
+1.05%
1M Performance:
+17.44%
6M Performance:
+1.55%
1Y Performance:
+15.37%
1-Day Range:
$12.13
$13.46
1-Week Range:
$11.16
$13.46
52-Week Range:
$6.26
$21.41
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
Name
Coeptis Therapeutics Holdings Inc
Sector
Industry
Phone
724-934-6467
Address
105 BRADFORD ROAD, SUITE 420, WEXFORD
Compare COEP vs MOBBW, PSNYW, SHMD, GOODO, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
6.99 | 2.70M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.00 | 2.87B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.50 | 350.59M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.26 | 465.95M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.18 | 372.90M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
45.37 | 0 | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc Stock (COEP) Latest News
How Coeptis Therapeutics Holdings Inc. (COEP) Affects Rotational Strategy Timing - Stock Traders Daily
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 2.4% – Should You Sell? - Defense World
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 2.4%Should You Sell? - MarketBeat
COEP Technical Analysis & Stock Price Forecast - Intellectia AI
Coeptis Receives Shareholder Approval Towards Z Squared Merger - 富途牛牛
Quarterly Recap: Will Materialise NV Depositary Receipt benefit from AI trendsTrade Risk Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
COEPW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Coeptis Therapeutics Holdings Inc. Equity Warrant navigate macro headwindsWeekly Trade Recap & High Accuracy Buy Signal Tips - mfd.ru
Should I buy Coeptis Therapeutics Holdings Inc stock nowJuly 2025 Recap & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Aug Gainers: What is the target price for Coeptis Therapeutics Holdings Inc Equity Warrant stockJuly 2025 PreEarnings & Weekly High Conviction Ideas - baoquankhu1.vn
(COEP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Analyst Downgrade: What hedge funds are buying SVIIWJuly 2025 Trends & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
IPO Launch: Can Rhythm Pharmaceuticals Inc expand into new marketsJuly 2025 Momentum & Technical Confirmation Alerts - baoquankhu1.vn
Will Coeptis Therapeutics Holdings Inc. stock go up in YEAREntry Point & Community Verified Swing Trade Signals - mfd.ru
Retail Trends: Is Martin Midstream Partners LP Limited Partnership a strong candidate for buy and holdEarnings Overview Report & Capital Efficient Trading Techniques - baoquankhu1.vn
Published on: 2026-02-15 21:43:00 - baoquankhu1.vn
What are the risks of holding Coeptis Therapeutics Holdings Inc. Equity WarrantQuarterly Growth Report & Weekly Hot Stock Watchlists - mfd.ru
S P Trends: Should I hold or sell Coeptis Therapeutics Holdings Inc Equity Warrant now2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn
Why Coeptis Therapeutics Holdings Inc. stock could rally in 2025Share Buyback & Consistent Return Investment Signals - mfd.ru
What is Coeptis Therapeutics Holdings Inc. s revenue forecastJuly 2025 Intraday Action & Reliable Breakout Stock Forecasts - mfd.ru
What is the target price for Coeptis Therapeutics Holdings Inc. Equity Warrant stock2025 Technical Patterns & Low Risk High Reward Ideas - mfd.ru
Coeptis Therapeutics (COEP) director adds shares via option exercise, grant - Stock Titan
Insider Daniel Yerace at Coeptis (COEP) gains 30K shares via awards - Stock Titan
Will Coeptis Therapeutics Holdings Inc. Equity Warrant stock recover faster than peersWeekly Stock Recap & Consistent Profit Trade Alerts - mfd.ru
Can Coeptis Therapeutics Holdings Inc. Equity Warrant expand into new marketsJuly 2025 Short Interest & High Return Trade Guides - mfd.ru
Coeptis Reprices Equity Awards and Accelerates Option Vesting - TipRanks
Published on: 2026-02-12 19:09:55 - mfd.ru
Published on: 2026-02-12 07:34:50 - mfd.ru
Big Picture: Can Coeptis Therapeutics Holdings Inc Equity Warrant stock double in the next yearTrade Volume Report & Daily Technical Forecast Reports - baoquankhu1.vn
Targets Report: Is Coeptis Therapeutics Holdings Inc stock a good pick for beginners2025 Major Catalysts & Advanced Technical Analysis Signals - baoquankhu1.vn
Responsive Playbooks and the COEP Inflection - Stock Traders Daily
Momentum Shift: Whats the beta of Coeptis Therapeutics Holdings Inc stockBond Market & Community Verified Trade Signals - baoquankhu1.vn
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 19.7%Should You Sell? - MarketBeat
Coeptis Therapeutics (NASDAQ:COEP) Shares Down 19.7%Should You Sell? - MarketBeat
Coeptis investors clear key hurdle for Z Squared merger - Stock Titan
Coeptis Shareholders Approve Merger, Spin-Out and Rebranding - TipRanks
Why Coeptis Therapeutics Holdings Inc. Equity Warrant stock could outperform in 2025 - mfd.ru
Vanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector Platform - The Globe and Mail
FinancialContentVanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector Platform - FinancialContent
CSG Systems International Extraordinary General Meeting: Shareholders Back Key Proposals, Merger Actions - Yahoo Finance
Understanding the Setup: (COEP) and Scalable Risk - Stock Traders Daily
Is Coeptis Therapeutics Holdings Inc. a speculative investmentJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - mfd.ru
Healthcare Stocks Surge in After-Hours Trading - intellectia.ai
Earnings Recap: What’s the fair value of Lakeshore Acquisition II Corp. Equity Right stockGlobal Markets & Free Community Supported Trade Ideas - baoquankhu1.vn
Portfolio Update: Can Coeptis Therapeutics Holdings Inc withstand a market correction2025 Key Highlights & Expert Approved Momentum Ideas - baoquankhu1.vn
Aug Highlights: What makes Coeptis Therapeutics Holdings Inc stock attractive todayJuly 2025 Review & Stock Portfolio Risk Management - baoquankhu1.vn
Coeptis launches venture group for AI and automation startups - MSN
S P Trends: Can Coeptis Therapeutics Holdings Inc Equity Warrant expand into new marketsEarnings Growth Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
The Technical Signals Behind (COEP) That Institutions Follow - Stock Traders Daily
Coeptis Therapeutics receives Nasdaq notice for delayed annual meeting By Investing.com - Investing.com South Africa
Coeptis Therapeutics receives Nasdaq notice for delayed annual meeting - Investing.com
Coeptis Therapeutics Holdings Inc Stock (COEP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Coeptis Therapeutics Holdings Inc Stock (COEP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Deschamps Philippe | Director |
Feb 11 '26 |
Option Exercise |
10.56 |
5,700 |
60,192 |
8,950 |
| Calise Chris | Director |
Feb 11 '26 |
Option Exercise |
10.56 |
5,700 |
60,192 |
368,741 |
| Mehalick David | CEO and President |
Feb 11 '26 |
Option Exercise |
7.05 |
148,875 |
1,049,569 |
330,192 |
| Cochran Christopher P. | Director |
Feb 11 '26 |
Option Exercise |
10.56 |
5,700 |
60,192 |
8,950 |
| Yerace Daniel Alexander | VP Operations |
Feb 11 '26 |
Option Exercise |
10.41 |
10,000 |
104,100 |
70,531 |
| Salkind Gene | Director |
Feb 11 '26 |
Option Exercise |
10.56 |
5,700 |
60,192 |
13,161 |
| DeSilva Tara | Director |
Feb 11 '26 |
Option Exercise |
10.56 |
5,700 |
60,192 |
8,950 |
| Sheehy Christine Elise | VP Compliance and Secy |
Feb 11 '26 |
Option Exercise |
10.56 |
1,000 |
10,560 |
64,031 |
3.69%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):